Predictions
Voyager Therapeutics Inc
Start price
Target price
Perf. (%)
€10.60
24.06.23
24.06.23
€20.00
31.12.25
31.12.25
-44.95%
08:58
08:58
Could be very worthwhile Investment >20% year
Zura Bio Ltd.
Start price
Target price
Perf. (%)
€9.25
24.06.23
24.06.23
€15.00
31.12.25
31.12.25
-68.00%
14.08.24
14.08.24
Could be very worthwhile Investment >20% year
Centessa Pharmaceuticals Plc
Start price
Target price
Perf. (%)
€5.80
24.06.23
24.06.23
€9.00
31.12.25
31.12.25
87.93%
15.08.24
15.08.24
Could be very worthwhile Investment >20% year
Context Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.14
24.06.23
24.06.23
€3.00
31.12.25
31.12.25
105.26%
15.08.24
15.08.24
Could be very worthwhile Investment >20% year
Quantum Battery Metals Corp.
Start price
Target price
Perf. (%)
€0.39
14.06.23
14.06.23
-
04.07.26
04.07.26
-87.15%
12:30
12:30
Plug Power Inc.
Start price
Target price
Perf. (%)
€8.62
12.06.23
12.06.23
-
03.07.25
03.07.25
-77.49%
12:20
12:20
Could be very worthwhile Investment >20% year
Capable Management
High valuation
Increased challenges to pay loans and raise capital
Oil-Dri Corporation Of America
Start price
Target price
Perf. (%)
€45.80
12.06.23
12.06.23
-
12.06.27
12.06.27
27.73%
15.08.24
15.08.24
Risky Investment
Kansai Electronic Power Corp. Inc.
Start price
Target price
Perf. (%)
€10.50
30.05.23
30.05.23
-
30.05.26
30.05.26
45.40%
15.08.24
15.08.24
Could be very worthwhile Investment >20% year
Ballard Power Systems Inc.
Start price
Target price
Perf. (%)
€3.96
30.05.23
30.05.23
-
30.12.26
30.12.26
-58.85%
12:26
12:26
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Capable Management
High valuation
Canada Cobalt Works Inc.
Start price
Target price
Perf. (%)
€0.040
30.05.23
30.05.23
-
31.07.25
31.07.25
-31.65%
22.01.24
22.01.24
Could be very worthwhile Investment >20% year
negative Cash Flow expected
Very low/no dividend yield expected
High valuation
Yara International
Start price
Target price
Perf. (%)
€36.07
28.05.23
28.05.23
€45.00
10.02.27
10.02.27
-26.99%
11:41
11:41
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€156.00
18.05.23
18.05.23
€169.00
31.10.24
31.10.24
-19.92%
12:32
12:32